Robert Schnabel

Statistics

Publications

Citations

179

H-Index

Active since

2016

Affiliations

University of Pannonia(Current)

Robert Schnabel is an author at University of Pannonia specializing in ulcerative colitis pharmacotherapy, inflammatory bowel disease therapy, and clinical remission.

Publications per year

2016–2021

Publications

Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial

Laurent Peyrin‐Biroulet, Ailsa Hart, Peter Bossuyt et al. · The Lancet. Gastroenterology & hepatology · 2021 · 93 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +15

Clinical Effects of a Topically Applied Toll-like Receptor 9 Agonist in Active Moderate-to-Severe Ulcerative Colitis

Raja Atreya, Stuart Bloom, Franco Scaldaferri et al. · Journal of Crohn s and Colitis · 2016 · 72 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Efficacy and safety of a novel high-dose mesalazine tablet in mild to moderate active ulcerative colitis: a double-blind, multicentre, randomised trial

Robert Schnabel, Jacek Romatowski, V. V. Pavlenko et al. · United European Gastroenterology Journal · 2017 · 14 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +12

1–3 of 3